Volume : VIII, Issue : IV, April - 2019

The Real Cost of Free Drug Samples:A Proposed Policy Solution

Dr. Gitanjali Mishra, Dr. Devashish Mishra

Abstract :

The improvements related to policy and legislation can create more competition in the pharmaceutical market. The improved pharmaceutical market competition would generate incentives for innovative medicines while regulating the distribution of free drug samples that lack value and have the substitute or alternative less expensive generic products. The provision of free drug samples strongly influences the physician‘s behavior and decision- making as physicians are more likely to prescribe expensive name- and drugs provided as a sample by the pharmaceutical company. Physicians‘ acceptance of drug samples not only undermines the use of prescribing less expensive generic alternatives, but it also contributes to the poor quality of patient care and increasing healthcare cost. The purpose of this paper is to propose a regulation regarding free drug samples that should be placed on the doctors and drug manufactures and they should be penalized if they provide loose samples of the prescription without proper side effects, drug interactions, doses, available generic drugs, storage instructions, and bookkeeping.

Keywords :

Article: Download PDF    DOI : https://www.doi.org/10.36106/gjra  

Cite This Article:

THE REAL COST OF FREE DRUG SAMPLES:A PROPOSED POLICY SOLUTION, Dr. Gitanjali Mishra, Dr. Devashish Mishra GLOBAL JOURNAL FOR RESEARCH ANALYSIS : Volume-8 | Issue-4 | April-2019


Number of Downloads : 154


References :